SEC Tracker
Get the app

Cannabis Bioscience International Holdings CBIH

Cannabis Bioscience International Holdings Q3 FY26: revenue $11K, down 25%; diluted EPS −$0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Cannabis Bioscience International Holdings reported for Q3 FY26, the quarter ended Feb 28, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$11K−25% from $15K in Q3 FY2510-Q income statement, on EDGAR
  2. Net income−$104KAgainst −$181K in Q3 FY2510-Q income statement, on EDGAR
  3. Diluted EPS−$0.00Against −$0.00 in Q3 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$90−84% from $548 in Q3 FY2510-Q balance sheet, on EDGAR
  5. Cash from operations−$15KAgainst −$83K in Q3 FY2510-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Cannabis Bioscience International Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.

  1. Hypha Labs FUNI public float $3M, Mar 31, 2025, over 18 months old
  2. iSpecimen ISPC public float $2M, Jun 30, 2025
  3. Foxo Technologies FOXO public float $2M, Jun 30, 2025
  4. Weed BUDZ public float $2M, Jun 30, 2025
  5. OneMedNet ONMD public float $14M, Jun 30, 2025